Cover Letter Attachments for Controlled Correspondences and ANDA Submissions: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 5, 2023
June 5, 2023
2b16776c-c5b5-4985-bb58-5746b2e77188
Related Documents
Post-Warning Letter Meetings Under GDUFA
Guidance DocumentJune 20, 2025Center for Drug Evaluation and Research
Controlled Correspondence Related to Generic Drug Development
Guidance DocumentMarch 18, 2024Center for Drug Evaluation and Research
Nonclinical Evaluation of the Immunotoxic Potential of Pharmaceuticals
Guidance DocumentJune 5, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox